Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07216989 · ClinicalTrials.gov registry record
Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting
A clinical trial of Insulin Resistance and Fasting, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT07216989: Recruiting study of Insulin Resistance and Fasting, sponsored by University of Minnesota.
NCT07216989 is a study of Insulin Resistance and Fasting that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 15 participants, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07216989, a study of Insulin Resistance and Fasting, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational study investigating how the metabolic and cell marker changes in Prolonged Fasting in the serum may be used against a cell-based model of disease for therapeutic purposes.
Primary Outcome
measured by % participants completing all the visits
Conditions Studied
Interventions
- OTHER Fasting
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2025-08-05 |
| Est. Completion | 2026-10-01 |
What NCT07216989 shows while recruiting
NCT07216989 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 245-participant average among 120 other Insulin Resistance trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Insulin Resistance appearing as the primary indexed condition, and to 1 intervention - of which Fasting is the first listed.
NCT07216989 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07216989 about?
NCT07216989 is a clinical study titled "Fastomics: Metabolic and Therapeutic Effects of Prolonged Fasting". This is an observational study investigating how the metabolic and cell marker changes in Prolonged Fasting in the serum may be used against a cell-based model of disease for therapeutic purposes.
What is the current status of trial NCT07216989?
This trial is currently recruiting. The enrollment target is 15 participants. The study started on 2025-08-05. Estimated completion is 2026-10-01.
What conditions does trial NCT07216989 study?
This clinical trial studies the following conditions: Insulin Resistance, Fasting.
What interventions are being tested in trial NCT07216989?
The interventions under investigation include: Fasting (OTHER).
Who is sponsoring clinical trial NCT07216989?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07216989 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Resistance
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07216989's enrollment target sits among peer trials
15 108th of 120 higher than 12 of 120 other Insulin Resistance trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insulin Resistance trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Small Extracellular Vesicles and Insulin Action
RECRUITING · NA
-
Metabolic Effects of Angiotensin-(1-7)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI